Suppr超能文献

按绩效付费与增加药物审查量相关,但与减少老年人不适当用药无关——一项观察性研究。

Pay for performance associated with increased volume of medication reviews but not with less inappropriate use of medications among the elderly - an observational study.

作者信息

Ödesjö H, Anell A, Boman A, Fastbom J, Franzén S, Thorn J, Björck S

机构信息

a Department of Public Health and Community Medicine , Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Primary Health Care, Region Västra Götaland , Gothenburg , Sweden.

b Lund University School of Economics and Management , Lund , Sweden.

出版信息

Scand J Prim Health Care. 2017 Sep;35(3):271-278. doi: 10.1080/02813432.2017.1358434. Epub 2017 Aug 23.

Abstract

OBJECTIVE

A pay for performance programme was introduced in 2009 by a Swedish county with 1.6 million inhabitants. A process measure with payment linked to coding for medication reviews among the elderly was adopted. We assessed the association with inappropriate medication for five years after baseline.

DESIGN AND SETTING

Observational study that compared medication for elderly patients enrolled at primary care units that coded for a high or low volume of medication reviews.

PATIENTS

144,222 individuals at 196 primary care centres, age 75 or older.

MAIN OUTCOME MEASURES

Percentage of patients receiving inappropriate drugs or polypharmacy during five years at primary care units with various levels of reported medication reviews.

RESULTS

The proportion of patients with a registered medication review had increased from 3.2% to 44.1% after five years. The high-coding units performed better for most indicators but had already done so at baseline. Primary care units with the lowest payment for coding for medication reviews improved just as well in terms of inappropriate drugs as units with the highest payment - from 13.0 to 8.5%, compared to 11.6 to 7.4% and from 13.6 to 7.2% vs 11.8 to 6.5% for polypharmacy.

CONCLUSIONS

Payment linked to coding for medication reviews was associated with an increase in the percentage of patients for whom a medication review had been registered. However, the impact of payment on quality improvement is uncertain, given that units with the lowest payment for medication reviews improved equally well as units with the highest payment.

摘要

目的

2009年,瑞典一个拥有160万居民的县推出了一项绩效薪酬计划。该计划采用了一项过程指标,将支付与老年人药物审查编码挂钩。我们评估了基线后五年内与不适当用药之间的关联。

设计与背景

一项观察性研究,比较了在初级保健单位登记的老年患者的用药情况,这些单位对药物审查的编码数量有高有低。

患者

196个初级保健中心的144,222名75岁及以上的个体。

主要结局指标

在不同药物审查报告水平的初级保健单位中,患者在五年内接受不适当药物或多重用药的百分比。

结果

五年后,有药物审查记录的患者比例从3.2%增至44.1%。大多数指标上,高编码单位表现更佳,但在基线时就已如此。药物审查编码支付最低的初级保健单位在不适当用药方面的改善程度与支付最高的单位相同——从不适当用药的13.0%降至8.5%,而支付最高的单位从不适当用药的11.6%降至7.4%;多重用药方面,支付最低的单位从13.6%降至7.2%,支付最高的单位从11.8%降至6.5%。

结论

与药物审查编码挂钩的支付与有药物审查记录的患者百分比增加有关。然而,鉴于药物审查编码支付最低的单位与支付最高的单位改善程度相同,支付对质量改进的影响尚不确定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验